Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
42°
Mostly Cloudy
Site search
Search
Menu
Subscribe
Home
News
Local News
Sports
Obituaries
Photos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Explore the Sheyenne
Best of 2023
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about NMLSF
Recent news which mentions NMLSF
Psyched: LSD For Major Depression, Canada's Psilocybin Macrodose Trial, Treatments For Multiple Sclerosis And More
April 24, 2023
Tickers
AWKNF
CMND
DRUG
HUGE
Tags
Cannabis
PSIL
Market News
From
Benzinga
Psychedelics And The Spectrum: Groundbreaking Study Details How One Firm Approaches Autism
April 20, 2023
Tickers
NMLSF
Tags
Market News
KGK Sciences
Cannabis
From
Benzinga
Psyched: Four New States With Reform Bills, Psilocybin For Genetic Disorders And Functional Neurological Disorder, Struggle For Access & More
February 21, 2023
Tickers
AGNPF
AWKNF
CYBN
DMTTF
Tags
Market News
PSIL
Cannabis
From
Benzinga
Health Canada Grants Exemption: Phase 2 Trial On Psilocybin For Genetic Disorder
February 14, 2023
Tickers
KONEF
NMLSF
Tags
NMLSF
Markets
Psilocybin Microdosing
From
Benzinga
First-Ever Clinical Trial On Magic Mushroom Therapy For Autism's Genetic Cause Receives Approval
December 27, 2022
Tickers
KONEF
NMLSF
Tags
Cannabis
Market News
Health Canada Approval
From
Benzinga
Psyched: Fed Guidelines And Research Production Quotas, Protests In Canada, Cal's Decrim Project
December 06, 2022
Tickers
AWKNF
BRAXF
DEA
FLHLF
Tags
Markets
Psychedelic Research
XTXXF
From
Benzinga
Psychedelic Partnership To Test Psilocybin For FXS In First Phase 2 Clinical Trial
November 30, 2022
Tickers
KONEF
NMLSF
Tags
News
KONEF
Psychedelics Research
From
Benzinga
Psychedelics For FXS Symptoms: New Research Contract For Upcoming Phase 2 Clinical Trial
November 17, 2022
Tickers
KONEF
NMLSF
Tags
NMLSF
Markets
psilocybin therapies
From
Benzinga
Psyched: Autopsy Reveals Death By Ketamine, LSD-Like Drugs Without Hallucinations, DEA & Right To Try Psilocybin
September 30, 2022
Tickers
ATAI
BMNDF
NMLSF
Tags
Psychedelics
Elijah McClain
Penny Stocks
From
Benzinga
Magic Mushroom In A Pill? New Microdose Plans Enter Clinical Studies: Here's What Scientists Want To Learn
September 29, 2022
Tickers
NMLSF
Tags
Benzinga
Penny Stocks
Autism
From
Benzinga
New Batch Of Psilocybin Microdose Capsules Is Ready, Learn All The Details
September 17, 2022
Tickers
NMLSF
Tags
Autism Spectrum Disorde
Toronto Institute of Pharmaceutical Technology
Psychedelics
From
Benzinga
More Patent Applications For Psilocybin: Learn About NOVA's Psychedelic Treatments For Neurological Diseases
June 16, 2022
Tickers
NMLSF
Tags
Markets
NMLSF
Legal
From
Benzinga
Psyched: Christie's Launches NFT Collection Supporting Psychedelic Science, Origin's Listing On CSE Gives Retail Investors Access To Private Companies
June 08, 2022
Tickers
CMNDF
CYBN
EHVVF
NMLSF
Tags
Psychedelics
CMNDF
SILFF
From
Benzinga
Nova Mentis NM-1001 Psilocybin Compound Gets DEA Approval For Export, Here's What Happened
June 07, 2022
Tickers
NMLSF
Tags
Toronto Institute of Pharmaceutical Technology
Psychedelics
Biotech
From
Benzinga
Nova Mentis Is Looking To Treat Autism With Psilocybin
April 07, 2022
Tickers
NMLSF
Tags
Nova Mentis Life Science Corp/
NMLSF
Markets
From
Benzinga
Psyched: Psilocybin Therapy Effective After One Year, Cybin & Deepak Chopra, Enveric Psilocybin Cancer Study
February 22, 2022
Tickers
CYBN
ENVB
FTRP
NMLSF
Tags
Cannabis
Markets
ENVB
From
Benzinga
This Psychedelics Penny Stock Is Up 55% After Successful Study On Microdosing For Autism
February 16, 2022
Tickers
NMLSF
Tags
Market News
NMLSF
Markets
From
Benzinga
Wellbeing Digital Sciences' Integrated Approach Aims To Capture Emerging Mental Health Tech And Psychedelics Market
February 08, 2022
Tickers
CGNSF
KONEF
NMLSF
Tags
Market News
NMLSF
Markets
From
Benzinga
Wellbeing Digital Sciences' Subsidiary KGK Science Forms Tactical Partnership With Nova Mentis
January 27, 2022
Tickers
KONEF
NMLSF
Tags
Markets
NMLSF
General
From
Benzinga
Psyched: Detroit Decriminalizes Psychedelics, Compass To Study Psilocybin For PTSD, Filaments Gets First-Ever FDA Approval
November 08, 2021
Tickers
CMPS
CYBN
FLHLF
NMLSF
Tags
FLHLF
Doug Drysdale
Markets
From
Benzinga
Psyched: British PM Considers Psychedelics, New Partnership To Study Psilocybin For Autism, Compass Gets Another Patent
October 26, 2021
Tickers
AWKNF
CMPS
CYBN
DMTTF
Tags
Ei/Ventures
CMPS
CYBN
From
Benzinga
Psyched: The 50 Publicly-listed Psychedelics Companies, Atai's New Subsidiary, PharmaTher Gets New Orphan Drug Designation
October 18, 2021
Tickers
AGNPF
ALID
ATAI
AWKNF
Tags
ATAI
AGNPF
ENTBF
From
Benzinga
There Are Now 50 Psychedelics Companies Listed In The U.S. - Here They Are
October 13, 2021
Tickers
AGNPF
ALID
ATAI
AWKNF
Tags
TRYPF
GHRS
ALID
From
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.